成人VR视频 and Moderna Launch Breakthrough RNA Project Through D2R to Advance Made-in-Canada Innovation
Montreal, QC, February 5, 2026 鈥� 成人VR视频 researchers, supported by the DNA to RNA (D2R) initiative and , are launching a pioneering research project that aims to further the fundamentals of ribonucleic acid (RNA) medicines by enhancing our understanding of the three-dimensional structure of full-length messenger RNA (mRNA).
The project brings together world-leading expertise in structural biology, nucleic acid chemistry, and advanced imaging to generate new experimental design principles that could transform how therapeutic mRNAs are designed, optimized, and manufactured.
Led by Martin Schmeing, a globally recognized leader in RNA structure and function, and co-investigator Hanadi Sleiman, a world-renowned expert in nucleic acid chemistry, the project aims to determine the first experimentally validated 3D structure of a therapeutically relevant mRNA.
For Moderna, the partnership is part of its long-standing commitment to advancing science through academic collaboration and to investing in Canadian research excellence. The project is supported through D2R鈥檚 Major Partnerships program, which was created to enable ambitious, high-impact research by tightly integrating academic excellence with industry insight.